Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Dendritic cells (DCs) are the most potent antigen-presenting cells, and have thus been used in clinical cancer vaccines. However, the effects of DC vaccines are still limited, leading researchers to explore novel ways to make them effective. In this study, we investigated whether human monocyte-deri...

Full description

Bibliographic Details

Published in:	Translational Oncology
Main Authors:	Tan-Huy Chu, Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Seo-Yeon Ahn, Mihee Kim, Ga-Young Song, Deok-Hwan Yang, Jae-Sook Ahn, Hyeoung-Joon Kim, Sung-Hoon Jung, Je-Jung Lee
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Subjects:	Immunology T cells cytokine induced killer cells natural killer cells multiple myeloma
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523322000754